Menu
Washingtoner
  • Home
  • Health
  • Books
  • Business
  • Artificial Intelligence
  • Technology
  • Music
  • Construction
  • Ai Memory
Washingtoner

First World Chronic Cough Day October 15, 2024
Washingtoner/10271470

Trending...
  • Tacoma: Applications Now Being Accepted for three Positions on the Urban Design Board
  • Spokane: Community Resources Available to Those Impacted by Fires
  • Independent West Texas Metal Multi-Instrumentalist & Producer. "MAD CHAD™" Russell Surpasses 1.9 Million Project Interactions Via DFGS Productions
Patient advocates unite to highlight a common challenge for their community

VIENNA & HENDERSONVILLE, Tenn. - Washingtoner -- Is a cough "just" a cough? You may be surprised to learn, most healthy people cough an average of 18 times per day. Imagine if you coughed 20 times per hour. Imagine counting more than 450 times per day for longer than eight weeks. This is the lived experience of more than 10% of the general population who are living with Recurrent Chronic Cough. October 15, 2024, marks the first World Chronic Cough Day.

Global Allergy & Airways Patient Platform (GAAPP) with its 150 patient organizations globally come together to raise awareness of the disease of recurrent chronic cough. GAAPP has joined forces with medical experts & community stakeholders, as well as governments to formally raise awareness & educate the public about this debilitating disease. They will host a global webinar with experts on October 15 and will release formal proclamations with state, federal & global policymakers recognizing the day. If you or someone you love is living with chronic cough, please connect with our community. To learn more about chronic cough or the World Chronic Cough Day 2024 activities, visit https://gaapp.org/wccd2024/

More on Washingtoner
  • Tacoma: Homicide Investigation – 2100 block of N 30th St
  • The City's Most Elegant Open-Air Dinner Party Returns September 12, 2026
  • Spokane: Incorrect Info Regarding Downgraded Evacuation Status on Popular App
  • FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
  • Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)

Contact
Tonya Winders
***@gaapp.org


Source: GAAPP
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Avenue Dental Care North Spokane Offers Free Emergency Care to Firefighters
  • Opteamix welcomes Girish Ramachandra to its leadership team as Senior Vice President of Client Services
  • Silicon Box Ships 500M Units at High Yield, Expands Production Capacity for Panel-Level Packaging
  • Statement from Tacoma Mayor Anders Ibsen on Spokane Wildfires
  • Why Baton Rouge's Humid Climate Can Contribute to Carpenter Ant Damage — J&J Exterminating Explains How to Protect Your Home
  • RPR Promotes Emily Line to Chief Strategy Officer and Janine Sieja to Chief Product Officer
  • Expanding Beyond Space as New Drone Market Opportunities Accelerate Growth: Ascent Solar Technologies (N A S D A Q: ASTI)
  • Lauren Merrell, Dale Sorensen Real Estate, announces price improvement for an extraordinary island retreat
  • Spokane: Construction Impacts for Freya Street Corridor
  • Spokane: City Service Adjustments During Fire Response
  • Qustone Launches Human-Centered Professional Network
  • Portalz Publishes FES World First Architecture Introducing a New Cryptographic Platform
  • ExtraCarry Sponsors Threat Response's Defensive Tactics Camp for Third Consecutive Year
  • ExtraCarry Sponsors the World Revolver Championship
  • Tacoma City Council Funds Pilot with St. Leo Food Connection to Expand Food Access at Tacoma Public Library
  • Tacoma: Applications Now Being Accepted for three Positions on the Urban Design Board
  • Spokane: Wildfire and Insurance Informational Session
  • Premier Expands Presence with New Bellevue Flexible Workspace Location
  • Haven Treatment Center In-Network with MODA Health, Expanding Access to Behavioral Health
  • Cellofest Brings Free Cello Concerts and Community Events to Bethany Beach August 5–16
_catLbl0 _catLbl1

Popular on Washingtoner

  • Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board - 111
  • Qscription Technologies Appoints Radiology Industry Veteran Elliot Silverman to Advisory Board
  • Spokane: Camp Sekani Update 7/9/26
  • Kolbus Introduces the Next Step in Casemaking Efficiency
  • Studica Robotics Supports Robotics Training Camp for WorldSkills Shanghai 2026
  • Florida Law Advisers, P.A. Named Best Divorce Firm of 2026 by Expert Law Attorneys
  • Sahar Education Invites You to Celebrate Afghan Culture and Community
  • J. Kenton Pierce Wins Prometheus Award for Best Novel
  • Spokane: Mayor Brown Joins 10th Bloomberg Harvard City Leadership Initiative Class to Strengthen Local Government and Advance Resident Priorities
  • Boston Industrial Solutions Launches New Citrine® SA1-370 Silicone Glue for Permanent Adhesion

Similar on Washingtoner

  • FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
  • Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
  • Avenue Dental Care North Spokane Offers Free Emergency Care to Firefighters
  • Haven Treatment Center In-Network with MODA Health, Expanding Access to Behavioral Health
  • Haven Treatment Center Achieves IMD Certification, Expanding Access to Residential Care
  • FDA Food Recall Notices After Outbreak Linked to 98 Hospitalizations: Practical Tips for Safer Grocery Shopping
  • Aderra Opens in Magnolia, Texas, Offering a New Model for 62+ Homeownership
  • Are "Buck Teeth" Hereditary? Spokane Valley Dentist Explains Children's Smile Development
  • James Richey, CEO of JouleFit, to Be Featured on the July Edition of the Longevity Leaders Project
  • DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute